Sonus Microsystems

Profusa, Inc.PFSA · Medical DevicesBerkeley, United States

62% matchPublic

Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into actionable health insights, primarily to empower individuals and clinicians in the management of persistent health challenges like diabetes and critical limb ischemia.

EchoNous, Inc.Medical DevicesUnited States

70% matchPrivate

EchoNous, Inc. is a medical device company headquartered in Redmond, Washington. The company specializes in developing advanced handheld ultrasound tools and medical imaging systems such as the Kosmos platform.

ReThink Medical, Inc.Medical DevicesUnited States

69% matchPrivate

ReThink Medical, Inc. is headquartered in San Francisco, California, and develops novel multi-parameter medical sensors such as devices for heart failure monitoring.

CardioMEMS, Inc. was a U.S. medical-device company that developed wireless, implantable sensors for monitoring pulmonary artery pressure in patients with heart failure. Its technology, including the CardioMEMS HF System, helps clinicians detect worsening heart failure earlier and manage treatment remotely; the company was acquired by Abbott in 2014.

VentriPoint Diagnostics Ltd. is a medical technology company focused on developing and commercializing diagnostic tools worldwide. These innovative solutions are designed to monitor individuals afflicted with cardiovascular disease. At the core of their offerings is the Ventripoint Medical System (VMS), an advanced medical imaging platform. The VMS generates precise three-dimensional models of the heart's chambers, providing crucial volumetric and functional measurements. This system is further enhanced by its VMS+ software, which processes echocardiogram and magnetic resonance imaging (MRI) data to construct these 3D models. The VMS+ software ensures highly reproducible and accurate quantification of heart chamber volumes and ejection fraction. Beyond its current flagship system, VentriPoint Diagnostics is actively expanding its portfolio with a suite of specialized applications. These applications target various cardiac conditions and imaging techniques, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and heart complications stemming from Covid-19. Founded in 2004, the company operates from its headquarters in Toronto, Canada.

Signostics develops portable, handheld ultrasound imaging devices and related software for point-of-care use. Its products are intended for clinicians and healthcare providers who need bedside diagnostic imaging.